Regards Medicaid managed care coverage of pharmacogenomic testing
Refer to Committee
Email me when SB 387 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track SB 387. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill directs Medicaid managed care organizations to cover genetic tests that assess how a patient’s genes affect drug safety and effectiveness when treating depression or anxiety, provided a prescriber orders the test and it meets Medicare local coverage criteria. It also sets limits on prior‑authorization requirements and creates penalties for organizations that fail to follow the new rules.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about SB 387
3 free questions a day, no accountHearings
- House Medicaid: H. B. No. 795House Medicaid · Jun 2, 2026
- Senate Medicaid: S. B. No. 387Senate Medicaid · Jun 2, 2026
- Senate Medicaid: S. B. No. 313, S. B. No. 387, S. B. No. 386Senate Medicaid · Apr 14, 2026
History
- Referred to committee
- Introduced
Sponsors
- Louis W. Blessing, III (R) · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when SB 387 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track SB 387 freeOr ask your AI assistant about SB 387 directly:
Add to Claude, ChatGPT or Cursor